Xing Wei
3PUBLICATIONS
72CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Feb 11, 2026
Abrogation of Oncogenic RAS Signaling by a RAS(ON) Inhibitor Doublet Primes Immune-Refractory KRASG12C-Mutant NSCLC for Immune Checkpoint Blockade.Xing Wei, Cristina Blaj, M Ali Al-Radhawi
|Feb 24, 2025
Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers.James Cregg, Kristof Pota, Aidan C A Tomlinson
|Apr 09, 2024
Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers.Jingjing Jiang, Lingyan Jiang, Benjamin J Maldonato
Pageof 1
Frequent Collaborators
2 joint publications
Jingjing Jiang
2 joint publications
Lingyan Jiang
2 joint publications
Benjamin J Maldonato
2 joint publications
Matthew Holderfield
2 joint publications
Ida Aronchik
2 joint publications
James Cregg
2 joint publications
Zhican Wang
2 joint publications
Cristina Blaj
2 joint publications
Stephanie Chang
2 joint publications
James W Evans
